Molecular therapy set to protect at-risk patients against heart attack and stroke
Even a single dose of a specific ribonucleic acid molecule, known as a small interfering RNA (siRNA), offers patients at high risk of cardiovascular disease long-lasting protection against high LDL cholesterol – one of the main risk factors for heart attack and stroke. This is the result of a clinical study by researchers from Charite […]